PHP
REPL icon

Parkman Healthcare Partners’s Replimune Group REPL Stock Holding History

Parkman Healthcare Partners’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-896,710
Closed -$8.33M – 99
2025
Q2 		$8.33M Sell
896,710
-53,689
-6% -$468K 0.96% 37
2025
Q1 		$9.27M Buy
950,399
+80,640
+9% +$998K 1.1% 35
2024
Q4 		$10.5M Buy
869,759
+106,012
+14% +$1.29M 1.4% 26
2024
Q3 		$8.37M Buy
763,747
+238,747
+45% +$2.43M 1.07% 35
2024
Q2 		$4.72M Buy
+525,000
New +$3.66M 0.63% 54

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Parkman Healthcare Partners's REPL Position: Q3 2025 in Review

Parkman Healthcare Partners sold out of Replimune Group (REPL) in Q3 2025, closing a stake of 896,710 shares — an estimated $8.33M sold.

Parkman Healthcare Partners first reported a position in REPL in Q2 2024 and held it in 5 quarters. The position peaked at $10.5M in Q4 2024. 163 funds tracked by Wall St. Rank hold REPL as of Q3 2025.

  • Parkman Healthcare Partners reported no remaining Replimune Group position as of Q3 2025 after selling out during the quarter.
  • Parkman Healthcare Partners sold 896,710 Replimune Group shares in Q3 2025, an estimated $8.33M.
  • Parkman Healthcare Partners first reported a position in Replimune Group in Q2 2024 and held it in 5 quarters.
  • Parkman Healthcare Partners's Replimune Group position peaked at $10.5M in Q4 2024.
  • 163 funds tracked by Wall St. Rank held Replimune Group as of Q3 2025.

Based on Parkman Healthcare Partners's 13F filing for Q3 2025, filed 14 Nov 2025.